Lee, K.-W.; Kim, S.H.; Yoon, K.C.; Lee, J.-M.; Cho, J.-H.; Hong, S.K.; Yi, N.-J.; Han, S.-S.; Park, S.-J.; Suh, K.-S.
Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial. J. Clin. Med. 2020, 9, 3264.
https://doi.org/10.3390/jcm9103264
AMA Style
Lee K-W, Kim SH, Yoon KC, Lee J-M, Cho J-H, Hong SK, Yi N-J, Han S-S, Park S-J, Suh K-S.
Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial. Journal of Clinical Medicine. 2020; 9(10):3264.
https://doi.org/10.3390/jcm9103264
Chicago/Turabian Style
Lee, Kwang-Woong, Seong Hoon Kim, Kyung Chul Yoon, Jeong-Moo Lee, Jae-Hyung Cho, Suk Kyun Hong, Nam-Joon Yi, Sung-Sik Han, Sang-Jae Park, and Kyung-Suk Suh.
2020. "Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial" Journal of Clinical Medicine 9, no. 10: 3264.
https://doi.org/10.3390/jcm9103264
APA Style
Lee, K.-W., Kim, S. H., Yoon, K. C., Lee, J.-M., Cho, J.-H., Hong, S. K., Yi, N.-J., Han, S.-S., Park, S.-J., & Suh, K.-S.
(2020). Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial. Journal of Clinical Medicine, 9(10), 3264.
https://doi.org/10.3390/jcm9103264
